Jump to content
RemedySpot.com

An update on the cytokine network in RA

Rate this topic


Guest guest

Recommended Posts

Guest guest

Curr Opin Rheumatol. 2004 May;16(3):218-222.

An update on the cytokine network in rheumatoid arthritis.

Miossec P.

Department of Immunology and Rheumatology, Hopital Edouard Herriot,

Lyon, France.

PURPOSE OF REVIEW: To update the knowledge accumulated on the

contribution of cytokines to rheumatoid arthritis and related animal

models. Publications from the end of 2002 and 2003 period were analyzed

for a selection. RECENT FINDINGS: A better understanding of the clinical

results with tumor necrosis factor-alpha inhibitors has come from

studies in treated patients. The expected effect of infliximab on the

apoptosis of cells expressing tumor necrosis factor-alpha was not

observed in synovium biopsy specimens. The mode of action of tumor

necrosis factor-alpha on bone destruction has been clarified in

gene-defective mice. Tumor necrosis factor-alpha acts through

osteoclasts-an effect that is inhibited with osteoprotegerin. New

interleukin-1 inhibitors with a potential for increased efficacy, such

as interleukin-1trap, have been manufactured and are now being tested in

rheumatoid arthritis. The list of cytokines of interest for therapeutic

intervention has been growing rapidly. The results with animal models

have provided clues to control arthritis with natural interleukin-18

inhibitors, such as interleukin-18 BP. Additional results have been

accumulated that indicate the contribution of T cell subsets in

inflammation and destruction through the production of interleukin-17.

Synergistic interactions with other cytokines are critical in the

interleukin-17 tuning effects. Macrophage inhibitory factor was

described many years ago. Its comeback is based on properties of

synoviocyte activation and proliferation.

SUMMARY: Such findings are critical for a better understanding of

response heterogeneity in patients treated with the cytokine inhibitors

now on the market. New therapeutic approaches are been planned from

these results.

PMID: 15103248

I'll tell you where to go!

Mayo Clinic in Rochester

http://www.mayoclinic.org/rochester

s Hopkins Medicine

http://www.hopkinsmedicine.org

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...